Alzheimer's Association Commends United Kingdom's Approval of Leqembi, But Condemns Decision to Deny NHS Access
CHICAGO,Aug. 23,2024-- The Alzheimer\'s Association welcomes today\'s decision by the United Kingdom\'s Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqembi® (lecanemab)










